Tenofovir‐Related Nephrotoxicity in Human Immunodeficiency Virus–Infected Patients: Three Cases of Renal Failure, Fanconi Syndrome, and Nephrogenic Diabetes Insipidus
Top Cited Papers
Open Access
- 15 April 2003
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (8) , 1070-1073
- https://doi.org/10.1086/368314
Abstract
We report 3 cases of renal toxicity associated with use of the antiviral agent tenofovir. Renal failure, proximal tubular dysfunction, and nephrogeniKeywords
This publication has 12 references indexed in Scilit:
- Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind studyAIDS, 2002
- Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase InhibitorsAntimicrobial Agents and Chemotherapy, 2002
- The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trialAIDS, 2001
- Adefovir nephrotoxicity: Possible role of mitochondrial DNA depletionHuman Pathology, 2001
- HUMAN RENAL ORGANIC ANION TRANSPORTER 1 (hOAT1) AND ITS ROLE IN THE NEPHROTOXICITY OF ANTIVIRAL NUCLEOTIDE ANALOGSNucleosides, Nucleotides and Nucleic Acids, 2001
- Cidofovir‐Induced End‐Stage Renal FailureClinical Infectious Diseases, 1999
- Fanconi syndrome associated with cidofovir therapyAntimicrobial Agents and Chemotherapy, 1997
- Urinary stones in HIV-1-positive patients treated with indinavirThe Lancet, 1997
- Indinavir NephropathyNew England Journal of Medicine, 1997
- Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapyAmerican Journal of Kidney Diseases, 1996